Related Experiment Video
Updated: Sep 14, 2026

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
Published on: June 18, 2015
[Anthracycline use in breast cancer based on our current knowledge]
Gábor Rubovszky1, Alíz Nikolényi2, Katalin Boér3
1Mellkasi és Hasüregi Daganatok és Klinikai Farmakológiai Osztály, Országos Onkológiai Intézet, Budapest, Hungary. rubovszky.gabor@oncol.hu.
Abstract:
Anthracyclines have been a standard component of the curative treatment of breast cancer for decades. Due to the emergence of new anticancer drugs (taxanes, immunotherapy, antibody-drug conjugates) and potentially life-threatening and long-term side effects of anthracyclines, the range of indications for their use has narrowed in recent years and seems to be becoming clearer. The classification of breast cancers according to molecular subgroups and the ever-expanding clinical data allow the choice of applied treatments to be increasingly individualized, which has led to the decline of anthracyclines in most breast cancer subtypes. Our goal with our summary work is to facilitate everyday decisions regarding the use of anthracyclines by summarizing the available clinical evidence.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Inhibition of Cdk Activity
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Mitogens and the Cell Cycle
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
